UBS downgraded Albemarle (ALB) to Sell from Neutral with a price target of $57, down from $64. The firm believes lithium markets will remain oversupplied through 2026. While Albemarle realized pricing moved up modestly year-over-year, UBS’s 2026 lithium price forecast is 6%-15% below consensus, the analyst tells investors in a research note. The firm believes 2026 consensus EBITDA expectations for Albemarle are 14% too high.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Early notable gainers among liquid option names on July 10th
- Chemours, chemical maker peers jump after EPA withdraws new use rules
- Chemical stocks on the rise after new use rules withdrawn by EPA
- Early notable gainers among liquid option names on July 8th
- Early notable gainers among liquid option names on July 2nd